Astellas Pharma recentlyagreed to acquire Audentes Therapeutics, a move it expects will result in faster development of potentially best-in-class therapies for rare neuromuscular diseases, including muscular dystrophy (MD).
Audentes vectorized exon-skipping technology which uses a modified adeno-associated virus (AAV) vector to allow cells to skip over mutated sections of genes will complement Astellas own work, Kenji Yasukawa, president and CEO of Astellas, said in a press release.
Recent scientific and technological advances in genetic medicine have advanced the potential to deliver unprecedented and sustained value to patients, and even to curing diseases with a single intervention, Yasukawa said.
Audentes has developed a robust pipeline of promising product candidates which are complementary to our existing pipeline, including its lead program AT132, he added. By joining together with Audentes talented team, we are establishing a leading position in the field of gene therapy with the goal of addressing the unmet needs of patients living with serious, rare diseases.
The technology uses the modified AAV vector to deliver small molecules antisense oligonucleotides complementary to the RNA sequence of a gene of interest, which allow cells to skip over mutated exons while they are producing proteins.
Exons are the coding regions of genes that provide instructions to make proteins.
Audentes had started developing several therapies for Duchenne muscular dystrophy (DMD) based on its exon-skipping technology. These include AT702, AT751 and AT753.
All three treatment candidates use the same AAV delivery vector. However, as they target different DMD gene exons, the potential therapies are intended for distinct subgroups of patients. AT702 is designed to skip exon 2 and is meant for those who either have duplications in exon 2 or mutations in exons 1-5. AT751 is designed for those with mutations in exon 51, and AT753 for people with alterations in exon 53.
Audentes had also started developing and testing AT466, an experimental treatment for myotonic dystrophy type 1.
The acquisition also gives Astellas direct access to AT132, Audentes lead gene therapy candidate for the treatment ofX-linked myotubular myopathy.
AT132 uses an AAV8 viral vector to deliver a functional copy of the MTM1 gene to muscle cells. This enables the production of myotubularin, an important enzyme for the development and maintenance of muscle cells.
Matthew R. Patterson, chairman and CEO of Audentes, said his company is very pleased with the agreement. With its focus on innovative science and a global network of research, development and commercialization resources, we believe that operating as part of the Astellas organization optimally positions us to advance our pipeline programs and serve our patients, he said.
Under the terms of the agreement, Audentes will become an independent subsidiary of Astellas and will have access to scientific resources to accelerate the development and manufacturing of the combined product pipeline. The transaction, worth $3 billion, is expected to take place early this year.
Joana is currently completing her PhD in Biomedicine and Clinical Research at Universidade de Lisboa. She also holds a BSc in Biology and an MSc in Evolutionary and Developmental Biology from Universidade de Lisboa. Her work has been focused on the impact of non-canonical Wnt signaling in the collective behavior of endothelial cells cells that make up the lining of blood vessels found in the umbilical cord of newborns.
Total Posts: 42
Jos is a science news writer with a PhD in Neuroscience from Universidade of Porto, in Portugal. He has also studied Biochemistry at Universidade do Porto and was a postdoctoral associate at Weill Cornell Medicine, in New York, and at The University of Western Ontario in London, Ontario, Canada. His work has ranged from the association of central cardiovascular and pain control to the neurobiological basis of hypertension, and the molecular pathways driving Alzheimers disease.
Here is the original post:
- Concert Genetics Presents Real-World Data on Utilization of NGS-Based Diagnostic Tests in NCCN 2020 Abstract - news-herald.net - April 2nd, 2020
- What scientists know about COVID-19 -- and what they don't - PBS NewsHour - April 2nd, 2020
- UVA Finds Way to Improve Cancer Outcomes by Examining Patients' Genes - University of Virginia - April 2nd, 2020
- Brown Alpert Medical School Autism Expert on Latest Advances in Research and Testing - GoLocalProv - April 2nd, 2020
- Coronavirus testing is ramping up. Here are the new tests and how they work. - Livescience.com - April 2nd, 2020
- Muscular Dystrophy Association Announces Formation of Strategic Medical Advisory Team of Experts in Neuromuscular Care and Research - PRNewswire - April 2nd, 2020
- Modalis Obtains Access to Foundational CRISPR IP - BioSpace - April 2nd, 2020
- Group behind NYC COVID-19 tent hospital is forcing medical workers to abide by anti-gay statement of faith - Metro Weekly - April 2nd, 2020
- What is coronavirus and Covid-19? An explainer - CNN - April 2nd, 2020
- COVID-19 Vaccine: Here Are Steps It Will Need to Go Through During Development | Medicine - Sci-News.com - April 2nd, 2020
- Coronavirus morning update: SA deaths now 5, but 50 recoveries in CT, and lifesaving lockdown - Health24 - April 2nd, 2020
- Can India be an outlier in the spread of Covid-19? | Opinion - Hindustan Times - April 2nd, 2020
- Genetic Medicine | Department of Medicine - March 31st, 2020
- Institute of Genetic Medicine | Johns Hopkins Medicine - March 31st, 2020
- Biotech innovations to spur next phase of personalized care - ModernHealthcare.com - March 31st, 2020
- What is genomic medicine? An introduction to genetics in ... - March 31st, 2020
- Patients with Severe Forms of Coronavirus Disease Could Offer Clues to Treatment - Howard Hughes Medical Institute - March 31st, 2020
- Battelle and Wexner Medical Center create new diagnostic test for COVID-19 - The Ohio State University News - March 31st, 2020
- 8 strains of the coronavirus are circling the globe. Here's what clues they're giving scientists. - USA TODAY - March 31st, 2020
- MyoKardia Announces Mavacamten Treatment Well Tolerated and Significantly Reduced Biomarkers of Cardiac Injury and Wall Stress in Non-Obstructive... - March 31st, 2020
- 8 strains of coronavirus are circling the globe; heres the clues theyre giving scientists - Canton Repository - March 31st, 2020
- Keck professors receive grant to further retinal research - Daily Trojan Online - March 31st, 2020
- Myriad Seeks Japanese Regulatory Approval for its BRACAnalysis Diagnostic System in People with Advanced Pancreatic and Prostate Cancer -... - March 31st, 2020
- UB infectious disease doctor breaks down Covid-19 and its potential impact on WNY - Buffalo News - March 31st, 2020
- 2020 Canada Gairdner Awards Recognize World-renowned Scientists for Transformative Contributions to Research That Impact Human Health - Yahoo Finance - March 31st, 2020
- How the spiky coronavirus attacks your cells and makes them into little virus factories - Houston Chronicle - March 31st, 2020
- Scientists expanded the Capabilities of CRISPR gene editing technique - Tech Explorist - March 31st, 2020
- Eight strains of the coronavirus are circling the globe. They're giving scientists clues - Stuff.co.nz - March 31st, 2020
- EMA grants conditional marketing authorisation in EU for gene therapy Zolgensma - Express Healthcare - March 30th, 2020
- Genetic Medicine | Internal Medicine | Michigan Medicine ... - March 26th, 2020
- Genomics and Medicine | NHGRI - March 26th, 2020
- Q&A:Transforming genetic medicine as the medical standard of care (Includes interview) - Digital Journal - March 26th, 2020
- Bridging the gap study sequences Asian genomes to diversify genetic databases - University of Virginia The Cavalier Daily - March 26th, 2020
- Precision Medicine, Nanotechnology and the Rise of the Robot Now. Powered by - Now. Powered by Northrop Grumman. - March 26th, 2020
- Genomic assays: on the brink of revolutionising human healthcare - Drug Target Review - March 26th, 2020
- PA reactivating retired healthcare providers' licenses to treat COVID-19 patients - FOX43.com - March 26th, 2020
- How the Pandemic Will End - The Atlantic - March 26th, 2020
- You can't kill coronavirus. That's OK. - Mashable - March 26th, 2020
- 10 Groundbreaking Medical Discoveries Made in NYC - Untapped New York - Untapped New York - March 26th, 2020
- Coronavirus vaccine: when will it be ready? - The Guardian - March 26th, 2020
- Twelve Women Who Have Shaped The History of the BioHealth Capital Region - BioBuzz - March 26th, 2020
- Alnylam Pharmaceuticals and Gen Sign Distribution Agreement in Turkey for ONPATTRO (patisiran), the First-in-Class Gene-Silencing RNAi Therapeutic -... - March 26th, 2020
- The Harvard Wyss Institute's response to COVID-19: beating back the coronavirus - P&T Community - March 26th, 2020
- Football: Ryan Day and staff transitioning to work-from-home mode - OSU - The Lantern - March 26th, 2020
- How long will we have to wait for a coronavirus vaccine? - Telegraph.co.uk - March 26th, 2020
- Understanding SARS-CoV-2 and the drugs that might lessen its power - The Economist - March 16th, 2020
- Marine medicine: Understanding and treating infection types - National Fisherman - March 16th, 2020
- Rapid genetic testing becomes available to Calgary medical community - CTV News - March 16th, 2020
- Coronavirus vaccines and treatment: Everything you need to know - CNET - March 16th, 2020
- Researchers Predict Potential Spread And Seasonality For COVID-19 Based On Climate Where Virus Appears To Thrive - Herald-Mail Media - March 16th, 2020
- On the front lines of developing a test for the coronavirus - Jacksonville Journal-Courier - March 16th, 2020
- Race Is Real, But It's Not Genetic - SAPIENS - March 16th, 2020
- Genomics took a long time to fulfil its promise - The Economist - March 16th, 2020
- Why There Aren't Enough Coronavirus Tests in the U.S. - Popular Mechanics - March 16th, 2020
- UPMC ready to test for coronavirus; Collection site to open in Williamsport | News, Sports, Jobs - Lock Haven Express - March 16th, 2020
- Two Women Fell Sick From the Coronavirus. One Survived. - The New York Times - March 16th, 2020
- The New Game of Microbiology Clue: The Who, When, Where, and Why of the Novel Coronavirus - Psychiatric Times - March 16th, 2020
- Cancer Biomarker Market investigated in the latest research - WhaTech Technology and Markets News - March 16th, 2020
- GeneTx and Ultragenyx Announce First Patient Dosed in Phase 1/2 Clinical Trial of GTX-102 in Patients with Angelman Syndrome - BioSpace - March 16th, 2020
- GW Pharmaceuticals submits Type II Variation Application to the European Medicines Agency (EMA) to expand the use of EPIDYOLEX, (cannabidiol) oral... - March 16th, 2020
- Alzheimer's Brains Short Circuited by Defective Protein Connections - Genetic Engineering & Biotechnology News - March 16th, 2020
- New Study Shows Combining TERT Mutation Analyses With DermTech's PLA Provides Improved Sensitivity for Detecting Melanoma With Non-invasive Patches -... - March 16th, 2020
- Medical genetics - Wikipedia - January 10th, 2020
- Distribution of Genes Encoding Virulence Factors and the Genetic Diver | IDR - Dove Medical Press - January 10th, 2020
- In defence of imprecise medicine: the benefits of routine treatments for common diseases - The Conversation UK - January 10th, 2020
- IDEAYA Biosciences and Boston Children's Hospital Collaborate on Preclinical Evaluation of IDE196 for Sturge Weber Syndrome - a Rare Disease... - January 10th, 2020
- Study ties gene active in developing brain to autism - Spectrum - January 10th, 2020
- Faculty and alumni appointed to state medical boards - The South End - January 10th, 2020
- Why This Thematic Healthcare Could be a January Winner - ETF Trends - January 10th, 2020
- New year health kicks are great but your environment is also vital - The Guardian - January 10th, 2020
- Biofidelity and Agilent complete successful molecular assay study for rapid and accurate detection of key lung cancer mutations - BioSpace - January 10th, 2020
- Physicians' Education Resource Presents the 2nd Annual Precision Medicine Symposium in New York City - BioSpace - January 10th, 2020
- A Genetic Mutation Is Responsible for Mysterious Deaths in the Amish Community, Researchers Say - Gizmodo - January 10th, 2020
- Kyoto Univ.-distributed iPS cells found with abnormalities after differentiation - The Mainichi - January 10th, 2020
- The Importance of Understanding TargetProtein Interactions in Drug Discovery - Technology Networks - January 10th, 2020
- Webinar: How Providers are Harnessing the Power of Genomics to Improve Community Health - ModernHealthcare.com - January 5th, 2020
- These 2 Stocks Will Fall After the New Year - Motley Fool - January 5th, 2020
- Free Gene Therapy Available for Patients with Alzheimer's - HealthITAnalytics.com - January 5th, 2020
- Chinese Researcher Who Created Gene-Edited Babies Sentenced To 3 Years In Prison - NPR - January 5th, 2020
- Duke Researchers Garner Over $6 Million in NIH Funding to Fight Genetic Diseases - Duke Today - January 5th, 2020